Robbins Umeda LLP Is Investigating the Acquisition of Gerber Scientific, Inc.
Robbins Umeda LLP, a shareholder rights litigation firm, is interested in helping shareholders of Gerber Scientific, Inc. (NYSE: GRB). The firm has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the board of directors of Gerber in connection with their efforts to sell the company to funds affiliated with Vector Capital Corporation.
On June 13, 2011, Gerber and Vector announced they have entered into a definitive merger agreement under which funds affiliated with Vector will acquire Gerber. Under the terms of the merger agreement, shareholders of Gerber will receive $11.00 per share. In addition, each shareholder will receive for each share they own a non-transferable right to receive contingent cash payments at future times if recoveries are made pursuant to certain litigation claims in respect to U.S. Patent 5,537,135. The transaction is expected to close in the second half of 2011.
The investigation focuses on whether Gerber’s board is undertaking a fair process to obtain maximum value and adequately compensate its shareholders in light of recent positive financial results. On March 3, 2011, Gerber reported better than expected third quarter 2011 results. The company reported EPS of $0.07, beating the $0.01 per share loss expected by analysts, while the company’s quarterly revenue of $111.95 million came in above the $103.50 million expected by analysts, which was a 12.8% increase compared to the third quarter 2010.
If you own stock in Gerber and would like more information about your shareholder rights, please complete the form below and we will contact you directly. We also welcome you to call us at 800-350-6003.